NON VIRAL SYNTHETIC siRNA DELIVERY SYSTEM AN EFFICIENT TOOL FOR CANCER TREATMENT
Gajendra J C Gupta*, Priti P Pednekar, K R Jadhav, Sai V Chilajwar,Vilasrao J Kadam
ABSTRACT
RNA interference (RNAi) is an evolving conserved cellular process for
the regulation of gene expression for the treatment of cancer. RNAi is
induced by short (21-23 nt) duplexes of RNA, termed as short
interference RNA (siRNA) that can elicit highly sequence specific
gene silencing.Although several siRNA candidates for the treatment of
ocular and respiratory diseases are still undergoing clinical trials, but
some inherent challenges needed for the further development of
siRNAs for anti-cancer therapeutics, because systemic administration
will be required in most cases. In addition to nonspecific off target and
immune stimulation problems, appropriate dose delivery remains a
major hurdle. Synthetic siRNA are poly anionic macromolecules that
do not readily enter the cell and thus typically requires delivery system for effective gene
silencing.This review is intended to give the insight about the various Non-viral delivery
strategies including their characterization, chemical modification, conjugation, lipid-based
techniques, polymer-based nanosystems, and physical methods. Moreover, the current
progress in siRNA delivery systems for cancer treatment is further discussed.
Keywords: Gene expression, Gene silencing, Off target, Polyanionic macromolecules, RNA interference, siRNA
[Download Article]
[Download Certifiate]